HIGHLIGHTS
- who: Ioana Mihaela Citu and colleagues from the Department of Internal Medicine I, "Victor Babes" University of Medicine and Pharmacy Timisoara have published the research: Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester, in the Journal: Viruses 2022, 307 of /2022/
- what: An observational study was developed to evaluate pregnant women receiving the complete COVID-19 vaccination scheme using the BNT162b2 and Ad26.COV2.S and determine pregnancy-related outcomes in the mothers and their newborns as well as determining adverse events after . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.